Literature DB >> 395847

Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms. Report of nine cases, including three males.

M Wolff, F Silva, G Kaye.   

Abstract

This study pertains to an entity characterized by the presence of multiple intrapulmonary nodules, which consist of an admixture of bundles of well-differentiated smooth muscle cells and epithelial-lined spaces. These lesions have been frequently interpreted as a variant of hamartomas. However, in this review of the literature, and careful analysis of nine cases of this entity, we concluded that they should be considered metastases from smooth muscle tumors which incorporate some structures of mature lung parenchyma as they slowly expand. We affirm that the designation "fibroeliomyomatous hamartoma" should be discarded. Our cases occurred in six female and three male patients. In all but one female the primary source for lung metastases was uterus, while the male patients had primary lesions in the saphenous vein, diaphragm, and soft tissues. These lung lesions increase in size and number and are potentially fatal, though this may take many years. Even though the smooth muscle cells of the lung nodules appear bland on light microscopy, we were always able to demonstrate mitotic activity; electron microscopy indicated immaturity of the cells. For these reasons, we believe the tumors to represent metastatic leiomyosarcomas.

Entities:  

Mesh:

Year:  1979        PMID: 395847     DOI: 10.1097/00000478-197908000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  21 in total

1.  CD10- and CD34-positive periglandular stromal cells in pulmonary benign metastasizing leiomyoma with metaplastic adenomyomatous glands: an ultrastructural and immunohistochemical study.

Authors:  Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2005-02-02       Impact factor: 4.064

2.  Mesenchymal tumors of the skull base with particular reference to surgical management and outcome.

Authors:  J C Shotton; R Kuhwoede; U Fisch
Journal:  Skull Base Surg       Date:  1992

Review 3.  Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Authors:  Hen Prizant; Stephen R Hammes
Journal:  Endocrinology       Date:  2016-07-13       Impact factor: 4.736

4.  Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity.

Authors:  Jennelle C Hodge; Kathryn E Pearce; Amy C Clayton; Florin A Taran; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2014-01-08       Impact factor: 8.661

5.  Multiple benign metastasizing leiomyomas in the pelvic lymph nodes and biceps muscle: report of a case.

Authors:  Masayuki Tori; Hiroki Akamatsu; Shin Mizutani; Katsuhide Yoshidome; Tsukasa Oyama; Shigeyuki Ueshima; Masahiko Tsujimoto; Masaaki Nakahara
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

6.  Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses.

Authors:  Gerard J Nuovo; Thomas D Schmittgen
Journal:  Diagn Mol Pathol       Date:  2008-09

7.  Tuberous sclerosis with pulmonary involvement.

Authors:  B A Liberman; D W Chamberlain; R S Goldstein
Journal:  Can Med Assoc J       Date:  1984-02-01       Impact factor: 8.262

8.  Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.

Authors:  V Canzonieri; E S D'Amore; G Bartoloni; M Piazza; S Blandamura; A Carbone
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Solitary fibrous tumour of the pleura: an ultrastructural and immunohistochemical study.

Authors:  S Keating; G T Simon; I Alexopoulou; J M Kay
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

10.  Benign metastasizing leiomyoma of the lung: report of a case.

Authors:  Akira Mogi; Junko Hirato; Takayuki Kosaka; Ei Yamaki; Hiroyuki Kuwano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.